共 22 条
- [12] Real-world single-centre experience of rheumatoid arthritis patients requiring four or more higher cost drugs: response and duration of treatment Clinical Rheumatology, 2022, 41 : 2695 - 2700
- [18] USE OF SHORT-TERM EFFICACY TOXICITY TRADEOFFS TO SELECT 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - A METAANALYSIS OF PUBLISHED CLINICAL-TRIALS ARTHRITIS AND RHEUMATISM, 1992, 35 (10): : 1117 - 1125
- [19] Real life use of biologic drugs and disease-modifying anti-rheumatic drugs (DMARDs) and its relationship with clinical activity by DAS 28 score in rheumatoid arthritis. A retrospective study. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S374 - S374